Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 Mg Hard Capsules, El(26)a/02
Recall Summary Glenmark Pharmaceuticals Europe Limited is recalling one batch of Fingolimod Glenmark 0.5 mg capsules distributed in the United Kingdom because stability testing found the capsules dissolve slower than they should. This recall affects patients in the United Kingdom who have this medication.
- Recalling firm
- Glenmark Pharmaceuticals Europe Limited
- Reason
- Glenmark Pharmaceuticals Europe Limited is recalling one batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule dissolution.
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2026-01-21
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/273ddb46-432f-44f7-ba76-94245629a540